EHRA Premium Access

A method to identify which patients will have VT substrate ablation targets prior to ablation procedure

Topic: Ablation of Ventricular Arrhythmias

Congress Presentation

About the speaker

Doctor Melanie Burg

Mater Dei Hospital of Malta, Msida (Malta)
0 follower

8 more presentations in this session

Reproducible target transfer from electroanatomic mapping to radiotherapy planning systems for cardiac radioablation - cross-validation for the RAVENTA trial

Speaker: Doctor S. Hohmann (Hannover, DE)

Thumbnail

Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation

Speaker: Doctor J. Al-Sheikhli (Coventry, GB)

Thumbnail

Stereotactic Arrhythmia Radioablation (STAR) for refractory ventricular tachycardia (VT) - A preliminary report from the German multicenter RAVENTA study

Speaker: Doctor S. Hohmann (Hannover, DE)

Thumbnail

Impact of cardiac magnetic resonance channels to localize deceleration zones during VT ablation

Speaker: Doctor S. Vazquez-Calvo (Barcelona, ES)

Thumbnail

Sex differences in catheter ablation for ventricular tachycardia in structural heart disease: a single center 10-years experience.

Speaker: Doctor N. Tanese (Milan, IT)

Thumbnail

Access the full session

Ventricular Arrhythmias and SCD - Round 3 - Ablation

Speakers: Doctor M. Burg, Doctor S. Hohmann, Doctor J. Al-Sheikhli, Doctor S. Hohmann, Doctor S. Vazquez-Calvo...
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations